Mirion Technologies, Inc. (NYSE:MIR) Accelerates Growth After Large Equity And Note Offerings

Capital raises and a targeted acquisition plan create a material near-term supply-and-funding dynamic while mixed technical momentum and stretched valuation warrant caution.

Recent News

Late September filings and press releases show Mirion launched an underwritten public offering of Class A common stock and a concurrent convertible notes offering, later pricing an upsized equity sale and $325.0 million of 0.00% convertible senior notes due 2031 to fund the planned acquisition of Paragon Energy Solutions and related capped-call costs (announcements dated Sept. 24–26, 2025). An institutional filing in November noted adjustments in major holdings and an insider sale of 300,000 shares reported Nov. 22, 2025.

Technical Analysis

Directional indicators show an emerging trend environment: ADX at 20.16 signals an emerging trend rather than a well-established directional move, which frames near-term price sensitivity to incoming news and capital activity.

DI+ of 21.11 trending downward indicates bearish directional pressure, while DI- at 26.95 with a peak-and-reversal implies DI- has turned lower and therefore contributes a bullish directional response; together these patterns produce conflicting directional signals and increase short-term volatility risk.

MACD shows a dip-and-reversal pattern, signaling a shift toward bullish momentum, but MACD remains below its signal line (MACD -0.14 vs. signal 0.19), so momentum improvement lacks a confirmatory bullish crossover and therefore limits conviction in sustained upside.

MRO at 7.12 sits positive, indicating price currently sits above the model target and therefore carries a higher probability of mean reversion; the MRO trend decreasing reduces the near-term strength of that reversion signal and ties directly to the valuation pressure noted below.

RSI at 53.65 with a dip-and-reversal shows momentum recovering from a recent pullback while remaining near neutral; the indicator supports a modest bullish tilt but not an overbought condition.

Price sits at $25.42 above the 20-day ($25.30), 50-day ($24.82) and well above the 200-day average ($19.88), and the 12-day EMA shows a dip-and-reversal—price above most moving averages supports short-term upside potential, but the lack of MACD confirmation and the MRO signal argue for guarded expectations.

Volatility and sensitivity indicators amplify event risk: 42-day beta at 2.53 and elevated short-term volatility suggest outsized reactions to earnings, funding, or acquisition updates; current volume sits below the 10-day average, limiting conviction in intraday moves. Bollinger band placement keeps price inside 1x bands ($23.45–$27.16), implying room for both a measured squeeze higher and a reversion toward the middle band.

 


Fundamental Analysis

Profitability metrics show mixed operational progress. EBIT of $19.6M and EBITDA of $53.4M translate to an EBIT margin of 8.79%, which increased QoQ by 35.59% and rose YoY by 379.18%; despite those gains, the EBIT margin sits below the industry peer mean of 14.42% and below the industry peer median of 20.38%, indicating margin recovery yet remaining under peer central tendencies.

Operating margin equals 4.44% and gross margin equals 45.99%; both remain below respective industry peer means (operating peer mean 12.82%, gross peer mean 57.05%), highlighting lower operational leverage relative to peers despite recent QoQ improvement in some margin lines.

Earnings per share missed the latest consensus: actual EPS $0.01 versus estimate $0.02, an EPS surprise of -50%. Forward EPS sits at $0.1225 with a forward P/E of 147.44, while the trailing P/E reads 657.26; the trailing and forward multiples sit materially above the industry peer mean (trailing peer mean ~84.92; forward peer mean ~92.75), reflecting compressed reported earnings and elevated market valuation.

Valuation ratios present divergence: price-to-book at 3.15 sits below the industry peer mean of 4.26, while price-to-sales near 20.68 aligns closely with the industry peer mean of 20.82. Enterprise multiple and EV-to-revenue metrics run high (enterprise multiple ~97.47), and WMDST values the stock as over-valued given current earnings, cash-flow conversion and capital raises.

Cash generation and leverage show modest liquidity but meaningful leverage risk. Cash and short-term investments equal $268.7M and cash ratio approximates 0.99; current ratio stands at 2.54, both above the industry peer means and supporting near-term liquidity. Total debt equals $865.1M with net debt $570.2M and debt-to-EBITDA at 16.2x, while interest coverage at 1.66 sits far below the industry peer mean of 25.60—these figures indicate leverage places pressure on free-cash conversion and interest servicing flexibility.

Free cash flow equaled $3.6M (free cash flow yield ~0.08%), below the industry peer mean of ~0.74%, and free cash flow growth shows contraction YoY; operating cash flow remains positive but modest relative to enterprise value. Revenue totaled $222.9M with YoY revenue growth of 37.43%, though sequential revenue growth shows notable QoQ variability. The combination of strong top-line expansion, weak cash conversion, and high leverage underpins the over-valued determination.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-10-28
NEXT REPORT DATE: 2026-01-27
CASH FLOW  Begin Period Cash Flow 186.2 M
 Operating Cash Flow 12.4 M
 Capital Expenditures -8.80 M
 Change In Working Capital -26.40 M
 Dividends Paid
 Cash Flow Delta 76.8 M
 End Period Cash Flow 263.0 M
 
INCOME STATEMENT REVENUE
 Total Revenue 222.9 M
 Forward Revenue 186.7 M
COSTS
 Cost Of Revenue 120.4 M
 Depreciation 8.6 M
 Depreciation and Amortization 33.8 M
 Research and Development 10.0 M
 Total Operating Expenses 213.0 M
PROFITABILITY
 Gross Profit 102.5 M
 EBITDA 53.4 M
 EBIT 19.6 M
 Operating Income 9.9 M
 Interest Income 2.0 M
 Interest Expense 11.8 M
 Net Interest Income -9.80 M
 Income Before Tax 7.8 M
 Tax Provision -700.00 K
 Tax Rate 21.0 %
 Net Income 8.3 M
 Net Income From Continuing Operations 8.5 M
EARNINGS
 EPS Estimate 0.02
 EPS Actual 0.01
 EPS Difference -0.01
 EPS Surprise -50.0 %
 Forward EPS 0.12
 
BALANCE SHEET ASSETS
 Total Assets 2.7 B
 Intangible Assets 1.8 B
 Net Tangible Assets -385.60 M
 Total Current Assets 693.2 M
 Cash and Short-Term Investments 268.7 M
 Cash 262.6 M
 Net Receivables 142.2 M
 Inventory 145.1 M
 Long-Term Investments 13.8 M
LIABILITIES
 Accounts Payable 45.6 M
 Short-Term Debt 400.0 K
 Total Current Liabilities 272.4 M
 Net Debt 570.2 M
 Total Debt 865.1 M
 Total Liabilities 1.2 B
EQUITY
 Total Equity 1.5 B
 Retained Earnings -532.90 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 6.44
 Shares Outstanding 226.978 M
 Revenue Per-Share 0.98
VALUATION
 Market Capitalization 4.6 B
 Enterprise Value 5.2 B
 Enterprise Multiple 97.474
Enterprise Multiple QoQ 16.073 %
Enterprise Multiple YoY 75.262 %
Enterprise Multiple IPRWA high: 234.897
MIR: 97.474
median: 76.655
mean: 68.873
low: -228.246
 EV/R 23.352
CAPITAL STRUCTURE
 Asset To Equity 1.872
 Asset To Liability 2.236
 Debt To Capital 0.372
 Debt To Assets 0.316
Debt To Assets QoQ 15.309 %
Debt To Assets YoY 15.464 %
Debt To Assets IPRWA high: 1.297
MIR: 0.316
mean: 0.241
median: 0.167
low: 0.002
 Debt To Equity 0.592
Debt To Equity QoQ 23.649 %
Debt To Equity YoY 24.064 %
Debt To Equity IPRWA high: 2.971
MIR: 0.592
mean: 0.4
median: 0.266
low: -1.733
PRICE-BASED VALUATION
 Price To Book (P/B) 3.152
Price To Book QoQ 39.303 %
Price To Book YoY 92.028 %
Price To Book IPRWA high: 17.161
median: 4.499
mean: 4.26
MIR: 3.152
low: -7.981
 Price To Earnings (P/E) 657.259
Price To Earnings QoQ 344.345 %
Price To Earnings YoY 516.13 %
Price To Earnings IPRWA MIR: 657.259
high: 246.592
median: 104.657
mean: 84.922
low: -204.468
 PE/G Ratio -9.389
 Price To Sales (P/S) 20.676
Price To Sales QoQ 22.757 %
Price To Sales YoY 73.032 %
Price To Sales IPRWA high: 154.906
mean: 20.821
MIR: 20.676
median: 20.417
low: 0.297
FORWARD MULTIPLES
Forward P/E 147.437
Forward PE/G -2.106
Forward P/S 24.688
EFFICIENCY OPERATIONAL
 Operating Leverage 4.796
ASSET & SALES
 Asset Turnover Ratio 0.083
Asset Turnover Ratio QoQ 8.257 %
Asset Turnover Ratio YoY 5.872 %
Asset Turnover Ratio IPRWA high: 0.482
mean: 0.16
median: 0.135
MIR: 0.083
low: 0.0
 Receivables Turnover 1.537
Receivables Turnover Ratio QoQ 23.854 %
Receivables Turnover Ratio YoY 7.332 %
Receivables Turnover Ratio IPRWA high: 3.864
MIR: 1.537
mean: 1.492
median: 1.457
low: 0.477
 Inventory Turnover 0.834
Inventory Turnover Ratio QoQ 9.004 %
Inventory Turnover Ratio YoY 12.225 %
Inventory Turnover Ratio IPRWA high: 3.161
MIR: 0.834
mean: 0.739
median: 0.714
low: 0.003
 Days Sales Outstanding (DSO) 59.36
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 141.778
Cash Conversion Cycle Days QoQ 7.602 %
Cash Conversion Cycle Days YoY -2.755 %
Cash Conversion Cycle Days IPRWA high: 401.407
MIR: 141.778
mean: 139.394
median: 114.45
low: -252.738
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.53
 CapEx To Revenue -0.039
 CapEx To Depreciation -1.023
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 2.3 B
 Net Invested Capital 2.3 B
 Invested Capital 2.3 B
 Net Tangible Assets -385.60 M
 Net Working Capital 420.8 M
LIQUIDITY
 Cash Ratio 0.986
 Current Ratio 2.545
Current Ratio QoQ 14.261 %
Current Ratio YoY 16.624 %
Current Ratio IPRWA high: 14.715
MIR: 2.545
mean: 2.253
median: 1.849
low: 0.353
 Quick Ratio 2.012
Quick Ratio QoQ 19.366 %
Quick Ratio YoY 29.464 %
Quick Ratio IPRWA high: 10.15
MIR: 2.012
mean: 1.64
median: 1.303
low: 0.411
COVERAGE & LEVERAGE
 Debt To EBITDA 16.2
 Cost Of Debt 1.177 %
 Interest Coverage Ratio 1.661
Interest Coverage Ratio QoQ 58.494 %
Interest Coverage Ratio YoY 560.025 %
Interest Coverage Ratio IPRWA high: 274.877
mean: 25.603
median: 15.82
MIR: 1.661
low: -384.45
 Operating Cash Flow Ratio 0.147
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 41.92
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 4.273 %
 Revenue Growth 10.347 %
Revenue Growth QoQ -150.311 %
Revenue Growth YoY 37.429 %
Revenue Growth IPRWA high: 47.668 %
MIR: 10.347 %
median: 7.569 %
mean: 7.472 %
low: -33.065 %
 Earnings Growth -70.0 %
Earnings Growth QoQ 70.002 %
Earnings Growth YoY -204.999 %
Earnings Growth IPRWA high: 200.0 %
median: 15.596 %
mean: 15.372 %
MIR: -70.0 %
low: -227.273 %
MARGINS
 Gross Margin 45.985 %
Gross Margin QoQ -3.34 %
Gross Margin YoY -2.222 %
Gross Margin IPRWA high: 94.498 %
mean: 57.051 %
median: 56.435 %
MIR: 45.985 %
low: 6.0 %
 EBIT Margin 8.793 %
EBIT Margin QoQ 35.59 %
EBIT Margin YoY 379.183 %
EBIT Margin IPRWA high: 33.87 %
median: 20.382 %
mean: 14.423 %
MIR: 8.793 %
low: -1442.238 %
 Return On Sales (ROS) 4.441 %
Return On Sales QoQ -31.519 %
Return On Sales YoY 142.016 %
Return On Sales IPRWA high: 35.533 %
median: 18.417 %
mean: 12.824 %
MIR: 4.441 %
low: -1529.874 %
CASH FLOW
 Free Cash Flow (FCF) 3.6 M
 Free Cash Flow Yield 0.078 %
Free Cash Flow Yield QoQ -90.213 %
Free Cash Flow Yield YoY -53.012 %
Free Cash Flow Yield IPRWA high: 11.539 %
mean: 0.741 %
median: 0.679 %
MIR: 0.078 %
low: -40.868 %
 Free Cash Growth -86.716 %
Free Cash Growth QoQ 93.532 %
Free Cash Growth YoY -45.902 %
Free Cash Growth IPRWA high: 337.277 %
mean: 9.685 %
median: -1.288 %
MIR: -86.716 %
low: -261.538 %
 Free Cash To Net Income 0.434
 Cash Flow Margin 17.945 %
 Cash Flow To Earnings 4.819
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 0.31 %
Return On Assets QoQ 2718.182 %
Return On Assets YoY -169.82 %
Return On Assets IPRWA high: 19.773 %
median: 2.151 %
mean: 1.821 %
MIR: 0.31 %
low: -72.965 %
 Return On Capital Employed (ROCE) 0.795 %
 Return On Equity (ROE) 0.006
Return On Equity QoQ 2740.0 %
Return On Equity YoY -173.196 %
Return On Equity IPRWA high: 0.769
median: 0.035
MIR: 0.006
mean: 0.002
low: -1.731
 DuPont ROE 0.56 %
 Return On Invested Capital (ROIC) 0.675 %
Return On Invested Capital QoQ 69.173 %
Return On Invested Capital YoY -128.711 %
Return On Invested Capital IPRWA high: 20.851 %
mean: 2.947 %
median: 2.936 %
MIR: 0.675 %
low: -30.099 %

Six-Week Outlook

Capital markets activity—the upsized equity offering and convertible notes issuance—creates an immediate supply-and-funding dynamic that likely elevates downside sensitivity to execution and integration news around the Paragon Energy Solutions acquisition. Technical signals show an emerging trend with recovering momentum (MACD dip-and-reversal; RSI recovering) but lack a confirming MACD crossover and the MRO suggests price sits above modeled target, introducing mean-reversion risk.

Expect heightened intraday and short-term volatility driven by news flow and earnings/calendar events; the combination of elevated short-term beta and material capital raises means the stock can exhibit amplified moves in reaction to acquisition updates, filings, or revisions to guidance. Given the over-valued WMDST determination, fundamental vulnerabilities around interest coverage and free-cash yield amplify downside risk absent demonstrable cash-flow improvement or rapid post-acquisition synergy realization.

About Mirion Technologies, Inc.

Mirion Technologies, Inc. (NYSE:MIR) develops and delivers advanced radiation detection, measurement, analysis, and monitoring solutions across a global market. With operations spanning the United States, Canada, Europe, and Asia, Mirion caters to a diverse clientele including medical facilities, industrial companies, government agencies, and military organizations. The company organizes its offerings into two primary segments: Medical and Technologies. The Medical segment provides comprehensive solutions for radiation oncology quality assurance, dosimetry, and patient safety in diagnostic imaging and radiation therapy centers. It also offers products for radionuclide therapy, supporting applications in medical diagnostics, cancer treatment, and practitioner safety. The Technologies segment addresses critical radiation safety and measurement needs, supplying personal radiation detection and identification equipment, as well as analysis tools. Mirion’s extensive product portfolio includes nuclear medicines, dosimeters, contamination monitors, reactor instrumentation, and control systems. Additionally, the company offers medical and industrial imaging systems, alpha and gamma spectroscopy instruments, and various software solutions. Founded in 2005 and headquartered in Atlanta, Georgia, Mirion Technologies continues to serve a broad spectrum of industries, ensuring safety and precision in environments where radiation plays a critical role.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.